ATE167631T1 - Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen - Google Patents

Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen

Info

Publication number
ATE167631T1
ATE167631T1 AT95912261T AT95912261T ATE167631T1 AT E167631 T1 ATE167631 T1 AT E167631T1 AT 95912261 T AT95912261 T AT 95912261T AT 95912261 T AT95912261 T AT 95912261T AT E167631 T1 ATE167631 T1 AT E167631T1
Authority
AT
Austria
Prior art keywords
compositions
thrombolytically
anticoagulant
anticoagulants
effective amount
Prior art date
Application number
AT95912261T
Other languages
English (en)
Inventor
Ulrich Martin
Stephan Fischer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22811809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE167631(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of ATE167631T1 publication Critical patent/ATE167631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95912261T 1994-03-25 1995-03-22 Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen ATE167631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/217,618 US5510330A (en) 1994-03-25 1994-03-25 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.

Publications (1)

Publication Number Publication Date
ATE167631T1 true ATE167631T1 (de) 1998-07-15

Family

ID=22811809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95912261T ATE167631T1 (de) 1994-03-25 1995-03-22 Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen

Country Status (21)

Country Link
US (1) US5510330A (de)
EP (2) EP0850648A3 (de)
JP (1) JPH09510439A (de)
KR (1) KR100366982B1 (de)
CN (1) CN1090029C (de)
AT (1) ATE167631T1 (de)
AU (1) AU702470B2 (de)
BR (1) BR9507189A (de)
CA (1) CA2186390A1 (de)
CZ (1) CZ279596A3 (de)
DE (1) DE69503120T3 (de)
DK (1) DK0751785T4 (de)
ES (1) ES2119411T5 (de)
FI (1) FI120182B (de)
MX (1) MX9603925A (de)
NO (1) NO316584B1 (de)
NZ (1) NZ282417A (de)
PL (1) PL182165B1 (de)
RU (1) RU2166326C2 (de)
UA (1) UA41398C2 (de)
WO (1) WO1995026202A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846202B2 (en) 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US20070203520A1 (en) * 1995-06-07 2007-08-30 Dennis Griffin Endovascular filter
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6750201B1 (en) * 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
EP1521603B1 (de) * 2002-07-12 2011-01-19 Cook Incorporated Beschichtete medizinische vorrichtung
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
WO2005116623A2 (en) 2004-05-17 2005-12-08 Medtronic, Inc. Point of care heparin determination system
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
AR068914A1 (es) * 2007-10-18 2009-12-16 Paion Deutschland Gmbh Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia
US20110027337A1 (en) * 2007-12-21 2011-02-03 Ifxa A/S Protease inhibitor
WO2016073514A2 (en) 2014-11-03 2016-05-12 Thrombolytic Science, Llc Methods and compositions for safe and effective thrombolysis
WO2016122288A2 (ko) * 2015-01-30 2016-08-04 고려대학교산학협력단 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제
RU2622006C2 (ru) * 2015-06-15 2017-06-08 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) федеральный университет" (ФГАОУВПО КФУ) Применение рекомбинантного штамма bacillus subtilis eo-11 вкпм в-11978 в качестве продуцента субтилизиноподобной протеиназы, вещества с тромболитическими и антикоагулянтными свойствами
CN105396127A (zh) * 2015-11-13 2016-03-16 中国人民解放军第四军医大学 一种用于急性心肌梗死的冠状动脉溶栓剂
WO2018232305A1 (en) * 2017-06-16 2018-12-20 Thrombolytic Science, Llc Methods and compositions for thrombolysis
CN117534731A (zh) * 2021-09-24 2024-02-09 江西康之康中药科技有限公司 一种抗凝血肽及其在抗凝血产品上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
DK43387A (da) † 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
CA2064231A1 (en) * 1989-07-20 1991-01-21 John M. Maraganore Combinations and methods for treating or preventing thrombotic diseases
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5189019A (en) * 1990-04-23 1993-02-23 Merck & Co., Inc. Antistasin derived anticoagulant protein
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
ES2082465T3 (es) † 1991-04-16 1996-03-16 Boehringer Mannheim Gmbh Unidad farmaceutica de envasado que contiene activadores de plasminogeno para la administracion multiple de bolos.
AU664469B2 (en) † 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties

Also Published As

Publication number Publication date
NO964007L (no) 1996-11-25
NO964007D0 (no) 1996-09-24
AU1951195A (en) 1995-10-17
EP0850648A3 (de) 2004-03-31
EP0850648A2 (de) 1998-07-01
JPH09510439A (ja) 1997-10-21
NZ282417A (en) 1998-02-26
WO1995026202A1 (en) 1995-10-05
FI963802A (fi) 1996-09-24
US5510330A (en) 1996-04-23
CZ279596A3 (cs) 1998-01-14
EP0751785B2 (de) 2001-12-19
CN1144489A (zh) 1997-03-05
DK0751785T3 (da) 1999-04-06
DE69503120T2 (de) 1998-11-12
MX9603925A (es) 1997-04-30
BR9507189A (pt) 1997-09-09
PL316449A1 (en) 1997-01-20
CN1090029C (zh) 2002-09-04
FI120182B (fi) 2009-07-31
CA2186390A1 (en) 1995-10-05
NO316584B1 (no) 2004-03-01
ES2119411T5 (es) 2002-08-01
EP0751785B1 (de) 1998-06-24
UA41398C2 (uk) 2001-09-17
DK0751785T4 (da) 2002-04-15
FI963802A0 (fi) 1996-09-24
DE69503120T3 (de) 2003-08-14
RU2166326C2 (ru) 2001-05-10
DE69503120D1 (de) 1998-07-30
ES2119411T3 (es) 1998-10-01
PL182165B1 (pl) 2001-11-30
AU702470B2 (en) 1999-02-25
KR100366982B1 (ko) 2003-08-02
EP0751785A1 (de) 1997-01-08

Similar Documents

Publication Publication Date Title
ATE167631T1 (de) Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen
PT740650E (pt) Co-farmacos como um metodo de administracao controlada de farmacos
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
ES2168302T3 (es) Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e.
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
DK1393750T3 (da) Antistoffer til behandling af en immunsygdom
NO20022673L (no) Hydrofil bomullspute (pad) for hudpleie omfattende to forskjellige overflater
DE60238503D1 (de) Mit humanem cdr gepfropfte antikörper und antikörperfragmente davon
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
AR017723A1 (es) Uso de 4-(1-etil-propoxi)3,6-dimetil-2-(2,4,6-trimetil-fenoxi)piridina o (3,6-dimetil-2-(2,4,6-trimetil-fenoxi)-piridin-4-il)-(1-etil-propil)-amina, unprofarmaco de las mismas o una sal farmaceuticamente aceptable de las mismas o de dicho profarmaco para la preparacion de un medicamento para el trat
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE243196T1 (de) Piperidine und pyrrolidine
ATE173627T1 (de) Medizinische zusammensetzung
ATE165514T1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
DE69821498D1 (de) Verwendung von amifostin
ATE272405T1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
NO801387L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
ES2103871T3 (es) Medicamento para oftalmologia y su empleo.
DE69326627D1 (de) Therapeutisches Mittel gegen drohenden Abortus
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
NO304518B1 (no) Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0751785

Country of ref document: EP

EEIH Change in the person of patent owner